SLS - SELLAS Life Sciences Group, Inc.
IEX Last Trade
0.92
0.013 1.457%
Share volume: 1,190,446
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$0.91
-0.03
-0.03%
View ratios
| Fiscal Date | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-14 | 2024-08-13 | 2024-11-13 | |
| Cash flow financing | 26.646 M | 414.000 K | 19.690 M | |
| Other financing cash flows | 49.000 K | 355.000 K | 155.000 K | |
| Cash flow | 15.885 M | 0.000 | 0.000 | |
| Net income | -9.566 M | -7.470 M | -7.108 M | |
| Depreciation | 0.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | |
| Cash Change | 15.885 M | -9.268 M | 11.884 M |